Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

33,058 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Preclinical evaluation of RQ3013, a broad-spectrum mRNA vaccine against SARS-CoV-2 variants.
Tan S, Zhao J, Hu X, Li Y, Wu Z, Lu G, Yu Z, Du B, Liu Y, Li L, Chen Y, Li Y, Yao Y, Zhang X, Rao J, Gao G, Peng Y, Liu H, Yuan Z, Liu J, Wang Q, Hu H, Gao X, Zhou H, Yu H, Xu Y, Yu W, Feng L, Wang M, Shan C, Lu J, Lin J. Tan S, et al. Among authors: zhou h. Sci Bull (Beijing). 2023 Dec 30;68(24):3192-3206. doi: 10.1016/j.scib.2023.11.024. Epub 2023 Nov 14. Sci Bull (Beijing). 2023. PMID: 37993332 Free article.
RBD-homodimer, a COVID-19 subunit vaccine candidate, elicits immunogenicity and protection in rodents and nonhuman primates.
Pan X, Shi J, Hu X, Wu Y, Zeng L, Yao Y, Shang W, Liu K, Gao G, Guo W, Peng Y, Chen S, Gao X, Peng C, Rao J, Zhao J, Gong C, Zhou H, Lu Y, Wang Z, Hu X, Cong W, Fang L, Yan Y, Zhang J, Xiong H, Yi J, Yuan Z, Zhou P, Shan C, Xiao G. Pan X, et al. Among authors: zhou h, zhou p. Cell Discov. 2021 Sep 7;7(1):82. doi: 10.1038/s41421-021-00320-y. Cell Discov. 2021. PMID: 34493710 Free PMC article.
Safety, immunogenicity, and efficacy of an mRNA COVID-19 vaccine (RQ3013) given as the fourth booster following three doses of inactivated vaccines: a double-blinded, randomised, controlled, phase 3b trial.
Liu X, Sun Z, Wang Z, Chen J, Wu Q, Zheng Y, Yang X, Mo L, Yan X, Li W, Zou Y, Song H, Qian F, Lu J, Zhou H, Wang Y, Xiang Z, Yu H, Lin J, Yuan L, Zheng Y. Liu X, et al. Among authors: zhou h. EClinicalMedicine. 2023 Sep 21;64:102231. doi: 10.1016/j.eclinm.2023.102231. eCollection 2023 Oct. EClinicalMedicine. 2023. PMID: 37767190 Free PMC article.
Vγ2 x PD-L1, a Bispecific Antibody Targeting Both the Vγ2 TCR and PD-L1, Improves the Anti-Tumor Response of Vγ2Vδ2 T Cell.
Yang R, He Q, Zhou H, Gong C, Wang X, Song X, Luo F, Lei Y, Ni Q, Wang Z, Xu S, Xue Y, Zhang M, Wen H, Fang L, Zeng L, Yan Y, Shi J, Zhang J, Yi J, Zhou P. Yang R, et al. Among authors: zhou h, zhou p. Front Immunol. 2022 Jun 17;13:923969. doi: 10.3389/fimmu.2022.923969. eCollection 2022. Front Immunol. 2022. PMID: 35784353 Free PMC article.
Zuberitamab, an innovative anti-CD20 monoclonal antibody, for patients with primary immune thrombocytopenia in China: a randomized, double-blind, placebo-controlled, phase 2 study.
Xu M, Shu J, Qian S, Guo J, Gong Y, Huang R, Wang S, Zhou Z, Yuan G, Huang M, Lin LE, Lou S, Song Y, Liu Q, Zhou H, Mei H, Hu Y. Xu M, et al. Among authors: zhou h. Lancet Reg Health West Pac. 2024 May 20;47:101096. doi: 10.1016/j.lanwpc.2024.101096. eCollection 2024 Jun. Lancet Reg Health West Pac. 2024. PMID: 38808021 Free PMC article.
Strain-mediated multistate skyrmion for neuron devices.
Shi S, Zhao Y, Sun J, Yu G, Zhou H, Wang J. Shi S, et al. Among authors: zhou h. Nanoscale. 2024 May 28. doi: 10.1039/d4nr01464b. Online ahead of print. Nanoscale. 2024. PMID: 38805240
33,058 results
You have reached the last available page of results. Please see the User Guide for more information.